<!DOCTYPE html>
<html lang="en">
<head>
  
  
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    
    
    <link rel="canonical" href="https://jzpero.github.io/mednotes/Cardiology/Ischemic%20Heart%20Disease/Antiplatelet%20Therapy/Antithrombotic%20Therapy%20after%20PCI%20in%20Atrial%20Fibrillation/">
    <link rel="shortcut icon" href="../../../../img/favicon.ico">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" />
    <title>Antithrombotic Therapy after PCI in Atrial Fibrillation - MedNotes</title>
    <link href="../../../../css/bootstrap-3.3.7.min.css" rel="stylesheet">
    <link href="../../../../css/font-awesome-4.7.0.css" rel="stylesheet">
    <link href="../../../../css/base.css" rel="stylesheet">
    <link rel="stylesheet" href="../../../../css/highlight.css">
    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
        <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
        <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->

    <script src="../../../../js/jquery-3.2.1.min.js"></script>
    <script src="../../../../js/bootstrap-3.3.7.min.js"></script>
    <script src="../../../../js/highlight.pack.js"></script>
    
    <base target="_top">
    <script>
      var base_url = '../../../..';
      var is_top_frame = false;
        
        var pageToc = [
          {title: "Background", url: "#_top", children: [
              {title: "Historical Trials", url: "#historical-trials" },
          ]},
          {title: "New Trials Examining Dual-Pathway Antithrombotics for PCI + AF", url: "#new-trials-examining-dual-pathway-antithrombotics-for-pci-af", children: [
          ]},
          {title: "Summary", url: "#summary", children: [
          ]},
        ];

    </script>
    <script src="../../../../js/base.js"></script> 
</head>

<body>
<script>
if (is_top_frame) { $('body').addClass('wm-top-page'); }
</script>



<div class="container-fluid wm-page-content">
  <a name="_top"></a>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../Interrupting%20DAPT%20for%20Non-Cardiac%20Surgery/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../Interrupting%20DAPT%20for%20Non-Cardiac%20Surgery/" class="btn btn-xs btn-link">
        Resources
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../ASA%20for%20Primary%20Prevention/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../ASA%20for%20Primary%20Prevention/" class="btn btn-xs btn-link">
        ASA for Primary Prevention
      </a>
    </div>
    
  </div>

    

    <p>See also <a href="../../Thrombotic%20Disease/Coronary%20Stent%20Thrombosis/">Coronary Stent Thrombosis</a>.</p>
<h1 id="background">Background</h1>
<p>We know that:
1.  These patients need some sort of protection for stroke risk (from AF), and from in-stent thrombosis (from PCI).
2.  Triple therapy (ASA + P2Y12 + OAC) is effective, but increases bleeding risk.</p>
<p>Therefore, what is the optimal strategy after PCI (elective or for <a href="../../Thrombotic%20Disease/ACS/">ACS</a>) in patients with AF requiring anticoagulation for their AF (high stroke risk, CHADS2 &gt; 0)?</p>
<h2 id="historical-trials">Historical Trials</h2>
<p>2013 - <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)62177-1/fulltext">WOEST trial</a> as above. VKA + clopidogrel vs triple therapy. Reduced bleeding but underpowered for thrombosis differences.
2015 - <a href="https://www.wikijournalclub.org/wiki/ISAR-TRIPLE">ISAR-TRIPLE trial</a> showing triple therapy with 6 weeks of clopidogrel was noninferior to 6 months of clopidogrel (+ASA/VKA)</p>
<h1 id="new-trials-examining-dual-pathway-antithrombotics-for-pci-af">New Trials Examining Dual-Pathway Antithrombotics for PCI + AF</h1>
<table>
<thead>
<tr>
<th>Trial</th>
<th>Drug / Intervention</th>
<th>Notes</th>
</tr>
</thead>
<tbody>
<tr>
<td>PIONEER-AF (2016)</td>
<td>Rivaroxaban</td>
<td></td>
</tr>
<tr>
<td>RE-DUAL (2017)</td>
<td>Dabigatran</td>
<td></td>
</tr>
<tr>
<td>AUGUSTUS (2019)</td>
<td>Apixaban</td>
<td></td>
</tr>
<tr>
<td>ENTRUST-AF PCI (2019)</td>
<td>Edoxaban</td>
<td></td>
</tr>
</tbody>
</table>
<h1 id="summary">Summary</h1>
<p>2018 CCS Guidelines:
<img alt="" src="../_attachments/Pasted%20image%2020221005022548.png" /></p>

  <br>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../Interrupting%20DAPT%20for%20Non-Cardiac%20Surgery/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../Interrupting%20DAPT%20for%20Non-Cardiac%20Surgery/" class="btn btn-xs btn-link">
        Resources
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../ASA%20for%20Primary%20Prevention/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../ASA%20for%20Primary%20Prevention/" class="btn btn-xs btn-link">
        ASA for Primary Prevention
      </a>
    </div>
    
  </div>

    <br>
</div>

<footer class="container-fluid wm-page-content">
  <p>Documentation built with <a href="https://www.mkdocs.org/">MkDocs</a> using <a href="https://github.com/gristlabs/mkdocs-windmill">Windmill</a> theme by Grist Labs.</p>
</footer>

</body>
</html>